Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H11N3O2.ClH |
Molecular Weight | 205.642 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)C1=NC=C(N1C)[N+]([O-])=O
InChI
InChIKey=HOMIFIGVCCVRIG-UHFFFAOYSA-N
InChI=1S/C7H11N3O2.ClH/c1-5(2)7-8-4-6(9(7)3)10(11)12;/h4-5H,1-3H3;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C7H11N3O2 |
Molecular Weight | 169.1811 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Originator
Sources: http://www.google.ru/patents/US3961068 | https://getd.libs.uga.edu/pdfs/hu_jinghui_200212_phd.pdf
Curator's Comment: # Hoffmann-La Roche Inc.
Approval Year
Sample Use Guides
Ipronidazole is administered through the feed at levels of approximately 0.006253% (prevention) to 0.025% (treatment). Continuous feeding of ipronidazole at a concentration of 100 g/ton in feed has been shown to prevent swine dysentery. Administration of ipronidazole at 200 to 800 mg/gal of drinking water for 7 days was effective in treating swine dysentery.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7181959
2.3 uM/mg protein of Ipronidazole induced a 60% decrease in rabbit heart mitochondrial ADP-stimulated oxygen uptake using glutamate-malate as substrate.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:40:19 GMT 2023
by
admin
on
Fri Dec 15 19:40:19 GMT 2023
|
Record UNII |
87813M60WF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
256-491-9
Created by
admin on Fri Dec 15 19:40:19 GMT 2023 , Edited by admin on Fri Dec 15 19:40:19 GMT 2023
|
PRIMARY | |||
|
DTXSID50964406
Created by
admin on Fri Dec 15 19:40:19 GMT 2023 , Edited by admin on Fri Dec 15 19:40:19 GMT 2023
|
PRIMARY | |||
|
49791-86-8
Created by
admin on Fri Dec 15 19:40:19 GMT 2023 , Edited by admin on Fri Dec 15 19:40:19 GMT 2023
|
PRIMARY | |||
|
16205133
Created by
admin on Fri Dec 15 19:40:19 GMT 2023 , Edited by admin on Fri Dec 15 19:40:19 GMT 2023
|
PRIMARY | |||
|
87813M60WF
Created by
admin on Fri Dec 15 19:40:19 GMT 2023 , Edited by admin on Fri Dec 15 19:40:19 GMT 2023
|
PRIMARY | |||
|
m6393
Created by
admin on Fri Dec 15 19:40:19 GMT 2023 , Edited by admin on Fri Dec 15 19:40:19 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |